Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  cobimetinib
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Cobimetinib and Vemurafenib in Treating Patients with Melanoma That Has Spread To the Brain
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 13-123, NCI-2015-00016, ML29155, NCT02230306
A Study of Cobimetinib in Combination With Paclitaxel as First-line Treatment for Patients With Metastatic Triple-negative Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: WO29479, NCI-2015-00443, 2014-002230-32, NCT02322814
A Study of MEHD7945A and Cobimetinib (GDC-0973) in Patients With Locally Advanced or Metastatic Cancers With Mutant KRAS
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GO29030, NCI-2014-00008, 2013-001910-14, NCT01986166
A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GO29653, NCI-2015-00884, 2015-000092-27, NCT02457793
Vemurafenib and Cobimetinib in Treating Patients with Stage III-IV Melanoma That Cannot Be Removed by Surgery
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: J1517, NCI-2015-01387, NCT02427893
Start Over